Expression of neutrophil antigens after 10 days of granulocyte-colony- stimulating factor

Transfusion

Volumn 38, Issue 7, 1998, Pages 663-668

  Stroncek, D F ^a   Jaszcz, W ^b,c   Herr, G P ^d   Clay, M E ^e,f   McCullough, J ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Dept of Lab Medicine and Pathology ^*

^c UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MICROSOMAL AMINOPEPTIDASE;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOCYTE TRANSFUSION; GRANULOCYTOSIS; GROWTH STIMULATION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPENIA; NEUTROPHIL;

EID: 0031875019     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38798346635.x     Document Type: Article

References (22)

1. Korbling M, Prezepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-65.
2. Schmitz N, Dreger P, Suttrop M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-72.
3. Bensinger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood 1996;88:2794-800.
4. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
5. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
6. Leitman SF, Oblitas JM, Emmons R, et al. Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life threatening infections (abstract). Blood 1996;88:331a.
7. Kerst JM, de Haas M, van der Schoot CE, et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 1993;82:3265-72.
8. Homburg CH, de Hass M, von dem Borne AE, et al. Human neutrophils lose their surface FcyII and acquire annexin V binding sites during aptosis in vitro. Blood 1995;85:532-40.
9. De Haas M, Kerst JM, van der School CE, et al. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994;84:3885-94.
10. Wright SD, Ramos RA, Tobias PS, et al. CD14, a receptor for complexes of lipopolysaccaride (LPS) and LPS binding protein. Science 1990;249:1431-3.
11. Menitove JE, ed. Standards for blood banks and transfusion services. 18th ed. Bethesda: American Association of Blood Banks, 1997.
12. Stroncek DF, Shankar RA, Noren PA, et al. Analysis of the expression of NB1 antigen using two monoclonal antibodies. Transfusion 1996;36:168-74.
13. Oshaka A, Saionji K, Sato N, et al. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leukocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br J Haematol 1993;84:574-80.
14. Stroncek DF, Skubitz KM, McCullough J. Biochemical characterization of the neutrophil-specific antigen NB1. Blood 1990;75:744-55.
15. Goldschmeding R, van Dalen CM, Faber N, et al. Further characterization of the NB1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophils. Br J Haematol 1992;81:336-45.
16. Avalors BR, Gasson JC, Hedvat C, et al. Human granulocyte-colony stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 1990;75:851-7.
17. Kitagawa S, Yuo A, Souza LM, et al. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by chemotactic peptide. Biochem Biophys Res Commun 1987;144:1143-7.
18. Yong KL, Linch DC. Differential effects of granulocyte-and granulocyte-macrophage colony-stimulating factors (G-and GM-CSF) on neutrophil adhesion in vitro and in vivo. Eur J Haematol 1992;49:251-9.
19. De Haas M, Kleijer M, van Zwieten R, et al. Neutrophil FcγRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 1995;86:2403-13.
20. Adkins D, Goodgold H, Hendershott L, et al. Indium-labeled white blood cells apheresed from donors receiving G-CSF localized to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1997;19:809-12.
21. McCullough J, Clay ME, Hurd D, et al. Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of lll-Indium labeled granulocytes. Blood 1986;67:522-8.
22. Anderlini P, Korbling M, Dale D, et al. Allogeneic blood stem cell transplantation: considerations for donors (editorial). Blood 1997;90:903-8.